Title:

Indonesia: Pharmaceutical

Price:$675.00
Publication Date:Jan 29, 2008
Source:ISI Analytics
Abstract:The Indonesian pharmaceutical sector experienced a growth in value, from USD1.6 billion at the end of 2006 to USD1.7 billion as at August 2007. Domestic manufacturing continues to develop and the possibilities of mergers between leading state-owned companies should boost the industry further. In 2006, Indonesian pharmaceutical companies controlled 65% of prescription sales and 75% of over-the-counter medicines relative to their foreign counterparts. Also, due to the decrease in generic drugs prices in 2006, it is anticipated that the generic drugs market will grow at an accelerated pace.
Word Count:6122
Length:19 Pages
Document ID:IP1
Industry:Pharmaceutical
Country:Indonesia
Format:Adobe Acrobat Adobe Acrobat
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $675.00




ISI Research Reports

Insight and analysis from ISI own on-the-ground analysts in the emerging markets, who combine original research with data from our proprietary industry databases.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions